Ferrlecit and Morphine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ferrlecit (sodium ferric gluconate complex) and Morphine (morphine sulfate). Common drug interactions include pitting oedema among females and blood uric acid decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Ferrlecit and Morphine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Ferrlecit?

Ferrlecit has active ingredients of sodium ferric gluconate complex. eHealthMe is studying from 2,376 Ferrlecit users. Check the latest studies of Ferrlecit.

What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,914 Morphine users. Check the latest studies of Morphine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

20 people who take Ferrlecit and Morphine together, and have interactions are studied.

Ferrlecit and Morphine drug interactions.

What are the common drug interactions of Ferrlecit and Morphine, by gender? *:

female:

  1. Pitting oedema (skin discoloration)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Skin fibrosis (fibrous tissue formation on skin)
  4. Skin hyperpigmentation (disorders affect the colour of your skin)
  5. Skin necrosis (skin damage)
  6. Skin ulcer
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Upper extremity mass
  9. Mobility decreased (ability to move is reduced)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

male:

  1. Blood uric acid decreased
  2. Bradycardia (abnormally slow heart action)
  3. Asthenia (weakness)
  4. Bladder discomfort
  5. Cachexia (loss of weight)
  6. Catatonia (unresponsive to external stimuli)
  7. Chest pain
  8. Chronic hepatic failure (long lasting liver failure)
  9. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  10. Communication disorder (speech and language disorder)

What are the common drug interactions of Ferrlecit and Morphine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Hypotension (abnormally low blood pressure)
  3. Vomiting
  4. Renal failure acute (rapid kidney dysfunction)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

30-39:

n/a

40-49:

n/a

50-59:

  1. Abasia (inability to walk)
  2. Death
  3. Drug hypersensitivity
  4. Gait disturbance
  5. Generalised oedema (swelling all over the body)
  6. Mobility decreased (ability to move is reduced)
  7. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  10. Pain in extremity

60+:

  1. Blood uric acid decreased
  2. Bradycardia (abnormally slow heart action)
  3. Asthenia (weakness)
  4. Bladder discomfort
  5. Blood creatine phosphokinase increased
  6. Cachexia (loss of weight)
  7. Catatonia (unresponsive to external stimuli)
  8. Chest pain
  9. Chronic hepatic failure (long lasting liver failure)
  10. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

What are the existing conditions these people have? *

  1. Lymphoedema (localized fluid retention and tissue swelling): 2 people, 10.00%
  2. Gout (uric acid crystals building up in the body): 2 people, 10.00%
  3. Breast Cancer: 2 people, 10.00%
  4. Anaemia (lack of blood): 2 people, 10.00%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.00%
  6. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 5.00%
  7. Nuclear Magnetic Resonance Imaging Brain: 1 person, 5.00%
  8. Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 5.00%
  9. Immunodeficiency Disorders: 1 person, 5.00%
  10. High Blood Cholesterol: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ferrlecit and Morphine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ferrlecit and Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ferrlecit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ferrlecit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sodium ferric gluconate complex and morphine sulfate (the active ingredients of Ferrlecit and Morphine, respectively), and Ferrlecit and Morphine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: